QDEL Profile
QuidelOrtho Corporation, headquartered in San Diego, California, specializes in advancing diagnostic testing technologies essential across the healthcare continuum. Established in 1979, the company operates through distinct business units: Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics, each dedicated to providing innovative solutions for clinical, transfusion medicine, and molecular diagnostic applications.
The Labs business unit focuses on clinical chemistry and immunoassay instruments and tests, critical for measuring bodily fluids' chemical targets and detecting disease markers. This unit also offers specialized diagnostic solutions across various therapeutic areas, supporting disease detection and management.
In Transfusion Medicine, QuidelOrtho provides immunohematology instruments for blood typing and donor screening instruments to ensure compatibility and safety in blood transfusions. This unit plays a pivotal role in safeguarding blood supply quality through rigorous infectious disease screening.
The Point-of-Care business unit offers rapid diagnostic tests suitable for diverse healthcare settings, delivering timely results crucial for immediate patient care decisions. Meanwhile, the Molecular Diagnostics unit specializes in polymerase chain reaction (PCR) thermocyclers and analyzers, facilitating sensitive and accurate genetic testing and analysis.
With a global presence spanning North America, Europe, the Middle East, Africa, China, and beyond, QuidelOrtho distributes its products directly through a dedicated sales force and a network of distributors. Its customers include physician offices, hospitals, clinical laboratories, retail clinics, pharmacies, and wellness screening centers, underscoring its commitment to enhancing healthcare outcomes through advanced diagnostic solutions.
|
